Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$761M |
| 3 |
Apple
AAPL
|
+$685M |
| 4 |
Amazon
AMZN
|
+$507M |
| 5 |
Cigna
CI
|
+$391M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$741M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$651M |
| 3 |
PX
Praxair Inc
PX
|
+$555M |
| 4 |
COL
Rockwell Collins
COL
|
+$293M |
| 5 |
CA
CA, Inc.
CA
|
+$178M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.64% |
| 2 | Financials | 15.19% |
| 3 | Healthcare | 14.85% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IIN
2676
DELISTED
IntriCon Corporation
IIN
| $2.25M | ﹤0.01% |
85,455
-4,089
| -5% | -$156K |
|
2677
AstraZeneca
AZN
$250B
| $2.25M | ﹤0.01% |
29,607
+3,190
| +12% | +$249K |
|
|
GRFS
2678
Grifois
GRFS
$5.4B
| $2.25M | ﹤0.01% |
122,324
+167
| +0.1% | +$3.32K |
|
2679
FirstService
FSV
$6.32B
| $2.24M | ﹤0.01% |
32,733
+1,391
| +4% | +$104K |
|
2680
Toyota
TM
$225B
| $2.24M | ﹤0.01% |
19,291
+2,501
| +15% | +$296K |
|
|
AVEO
2681
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $2.23M | ﹤0.01% |
139,458
+37,133
| +36% | +$817K |
|
|
VWTR
2682
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $2.23M | ﹤0.01% |
243,646
+10,684
| +5% | +$113K |
|
|
CBMG
2683
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $2.23M | ﹤0.01% |
126,067
+14,621
| +13% | +$248K |
|
|
REV
2684
DELISTED
Revlon, Inc.
REV
| $2.22M | ﹤0.01% |
88,040
-15,731
| -15% | -$388K |
|
2685
First Internet Bancorp
INBK
$255M
| $2.21M | ﹤0.01% |
108,017
+12,383
| +13% | +$311K |
|
2686
Vera Bradley
VRA
$98.7M
| $2.21M | ﹤0.01% |
257,642
-5,250
| -2% | -$61.7K |
|
|
MCBC
2687
DELISTED
Macatawa Bank Corp
MCBC
| $2.21M | ﹤0.01% |
229,283
+13,448
| +6% | +$140K |
|
|
ADVM
2688
DELISTED
Adverum Biotechnologies
ADVM
| $2.2M | ﹤0.01% |
69,860
+11,517
| +20% | +$468K |
|
|
SRGA
2689
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $2.19M | ﹤0.01% |
19,706
+828
| +4% | +$108K |
|
2690
Weyco Group
WEYS
$440M
| $2.18M | ﹤0.01% |
74,819
+3,525
| +5% | +$112K |
|
|
CWBC
2691
Community West Bancshares
CWBC
$684M
| $2.18M | ﹤0.01% |
115,407
+6,577
| +6% | +$131K |
|
|
AQ
2692
DELISTED
Aquantia Corp. Common Stock
AQ
| $2.18M | ﹤0.01% |
248,342
+11,662
| +5% | +$118K |
|
2693
Surgery Partners
SGRY
$2.03B
| $2.17M | ﹤0.01% |
221,341
+21,267
| +11% | +$285K |
|
|
CDMO
2694
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.16M | ﹤0.01% |
527,772
+27,685
| +6% | +$144K |
|
2695
RBB Bancorp
RBB
$455M
| $2.15M | ﹤0.01% |
122,667
+17,882
| +17% | +$384K |
|
|
AOD
2696
abrdn Total Dynamic Dividend Fund
AOD
$1.12B
| $2.15M | ﹤0.01% |
298,557
+25,554
| +9% | +$204K |
|
2697
Boston Omaha
BOC
$436M
| $2.15M | ﹤0.01% |
91,757
+8,280
| +10% | +$216K |
|
|
LJPC
2698
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $2.15M | ﹤0.01% |
227,484
+7,370
| +3% | +$111K |
|
2699
Sonos
SONO
$1.85B
| $2.14M | ﹤0.01% |
218,377
+61,229
| +39% | +$768K |
|
2700
Sabesp
SBS
$18.7B
| $2.12M | ﹤0.01% |
1,357,728
+559,653
| +70% | +$805K |
|
Similar funds
Geode Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Geode Capital Management held 4,266 positions worth $323B, down 8.8% from $355B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Geode Capital Management deployed $21.9B of net new capital in Q4 2018, opening 149 new positions and adding to 3,108 existing holdings. Its largest new stake was Linde: 6,406,340 shares worth $998M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Dell, an estimated $92.5M trimmed.
- Geode Capital Management's largest Q4 2018 buy was Linde: 6,406,340 shares worth $998M.
- Geode Capital Management added most to Microsoft in Q4 2018, an estimated $761M increase.
- Geode Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $92.5M.
- Geode Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $741M.
- Geode Capital Management's ten largest holdings make up 17% of its $323B portfolio in Q4 2018.
- Geode Capital Management opened 149 new positions and closed 120 in Q4 2018.
- Geode Capital Management's portfolio value fell 8.8% quarter-over-quarter to $323B.
Based on Geode Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.